Table 5. Financial costs of scaling-up HPV vaccine delivery in Tanzania, Uganda and Bhutan.

	Tanzania (C4P costing tool*) Program scaled-up	Tanzania (C4P costing tool*) Program scaled-up	Uganda (financial assessment to scale up from bridging study)	Bhutan national introduction with catch-up (based on expenditure data and 90% coverage)***	Average costs from prior four columns (not weighted by population)
Type of Estimation	Projected	Projected	Projected	Actual
Currency	US$ 2011	US$ 2011	US$ 2011	US$ 2010
Age of target population	10 yrs	10 yrs	10 yrs	12–18 yrs
Number of girls in target population	605,000	605,000	675,270	47,888
Delivery strategy	Periodicschool-based	Periodic healthfacility based	Periodic Integratedoutreach	Periodic school-based
Introduction costs per eligible girl ****	$3.07	$3.07	$2.82**	$3.02	$2.99
Recurrent costs per dose	$1.59	$1.17	$1.27	$1.50	$1.38
Recurrent costs for three doses per eligible girl	$4.78	$3.51	$3.81	$4.56	$4.17

*The C4P tool is the WHO Cervical Cancer Prevention and Control Costing Tool.

**Uganda’s estimate is the introduction cost per girl for scaling up to all districts, following the demonstration project–where there was already an investment in start-up activities.

***Estimates for Bhutan were obtained from available country expenditure data from the national introduction with catch-up vaccination rather than from a full costing through the collection of resource and cost data. Costs would probably vary upon switching to a national vaccination of a single cohort per year through facility-based services.

****The calculation of cost per eligible girl divides the costs of the program with full coverage (100%) by the total number of girls in the target population.